| CXSB2000038 | 重组抗RANKL全人单克隆抗体注射液 | denosumab | Injection | Biological Products(3.3) | Supplementary Application | 2020-08-04 | 山东博安生物技术有限公司 | Shandong BoAn Biotechnology Co Ltd | In Review | 2020-08-03 | view |
| CXSL1400119 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2015-01-06 | 山东博安生物技术有限公司 | Shandong BoAn Biotechnology Co Ltd | Certificate Issued | 2016-10-11 | view |
| CXSL1600080 | 重组抗RANKL全人单克隆抗体注射液 | denosumab | Injection | Biological Products(2) | New Drug Application | 2016-10-11 | 山东博安生物技术有限公司 | Shandong BoAn Biotechnology Co Ltd | Certificate Issued | 2017-06-09 | view |
| CXSL1600099 | 重组抗RANKL全人单克隆抗体注射液 | denosumab | Injection | Biological Products(2) | New Drug Application | 2016-12-05 | 山东博安生物技术有限公司 | Shandong BoAn Biotechnology Co Ltd | Certificate Issued | 2017-06-20 | view |
| CXSL1800132 | 重组人血管内皮生长因子受体-抗体融合蛋白眼用注射液 | | Injection | Biological Products(15) | New Drug Application | 2019-01-04 | 山东博安生物技术有限公司 | Shandong BoAn Biotechnology Co Ltd | In Review | 2019-01-02 | view |
| CXSL1900071 | 重组人血管内皮生长因子受体-抗体融合蛋白注射液 | | Injection | Biological Products(7) | New Drug Application | 2019-07-09 | 山东博安生物技术有限公司 | Shandong BoAn Biotechnology Co Ltd | In Review | 2019-07-08 | view |
| CXSL1900072 | 重组人血管内皮生长因子受体-抗体融合蛋白注射液 | | Injection | Biological Products(7) | New Drug Application | 2019-07-09 | 山东博安生物技术有限公司 | Shandong BoAn Biotechnology Co Ltd | In Review | 2019-07-08 | view |
| CXSL2100075 | LY01015注射液 | nivolumab | Injection | Biological Products(3.3) | New Drug Application | 2021-02-27 | 山东博安生物技术有限公司 | Shandong BoAn Biotechnology Co Ltd | In Review | 2021-02-26 | view |
| CXSL2100076 | LY01015注射液 | nivolumab | Injection | Biological Products(3.3) | New Drug Application | 2021-02-27 | 山东博安生物技术有限公司 | Shandong BoAn Biotechnology Co Ltd | In Review | 2021-02-26 | view |
